Pfizer stock climbs as first quarter earnings, revenue come ahead of estimates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Pfizer (PFE) Tops Q1 EPS by 29c, Beats on Revenue; Offers FY24 Guidance
May 1, 2024 6:46 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.82, $0.29 better than the analyst estimate of $0.53. Revenue for the quarter came in at $14.9 billion versus the consensus estimate of $14.04 billion.
GUIDANCE:
Pfizer sees FY2024 EPS of $2.15-$2.35, versus the consensus of $2.21. Pfizer sees... More
